165 related articles for article (PubMed ID: 17714414)
1. Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis.
Foo AH; Ramkumar S; Helke S; Branch DR
Transfusion; 2007 Dec; 47(12):2250-9. PubMed ID: 17714414
[TBL] [Abstract][Full Text] [Related]
2. Reduction of disulfide bonds within anti-D results in enhanced Fcgamma receptor blockade.
Kruspe AS; Katsman Y; Sakac D; Chagneau C; Glistvain A; Langler RF; Branch DR
Transfusion; 2009 May; 49(5):928-36. PubMed ID: 19170994
[TBL] [Abstract][Full Text] [Related]
3. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells.
Rampersad GC; Suck G; Sakac D; Fahim S; Foo A; Denomme GA; Langler RF; Branch DR
Transfusion; 2005 Mar; 45(3):384-93. PubMed ID: 15752156
[TBL] [Abstract][Full Text] [Related]
4. Structure-function studies for in vitro chemical inhibition of Fc gamma receptor-mediated phagocytosis.
Foo AH; Fletcher SP; Langler RF; Porter CH; Branch DR
Transfusion; 2007 Feb; 47(2):290-8. PubMed ID: 17302776
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes.
Perri D; Shabani F; Ziaeian G; Denomme GA
Transfus Apher Sci; 2008 Aug; 39(1):37-44. PubMed ID: 18614400
[TBL] [Abstract][Full Text] [Related]
6. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
[TBL] [Abstract][Full Text] [Related]
7. NA1/NA2 antisera inhibit FcgammaRI- but not FcgammaRII- mediated phagocytosis.
Flesch BK; Maass W; Neppert J
Vox Sang; 1998; 75(3):247-52. PubMed ID: 9852415
[TBL] [Abstract][Full Text] [Related]
8. Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cell.
Flesch BK; Vöge K; Henrichs T; Neppert J
Vox Sang; 2001; 81(2):128-33. PubMed ID: 11555474
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
[TBL] [Abstract][Full Text] [Related]
10. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
Bazin R; Lemieux R; Tremblay T; St-Amour I
Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
[TBL] [Abstract][Full Text] [Related]
11. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
12. Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration.
Shoham-Kessary H; Gershon H
Vox Sang; 1999; 77(1):33-9. PubMed ID: 10474088
[TBL] [Abstract][Full Text] [Related]
13. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura.
Aubin E; Lemieux R; Bazin R
Br J Haematol; 2007 Mar; 136(6):837-43. PubMed ID: 17341270
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antibody-dependent cellular phagocytosis by chimeric monoclonal antibodies with tandemly repeated Fc domains.
Nagashima H; Ootsubo M; Fukazawa M; Motoi S; Konakahara S; Masuho Y
J Biosci Bioeng; 2011 Apr; 111(4):391-6. PubMed ID: 21215693
[TBL] [Abstract][Full Text] [Related]
15. [Photometric detection of erythrocyte phagocytosis in the monocyte-macrophage assay].
Sibroswki W; Cassens U; Kühnl P
Beitr Infusionsther; 1990; 26():333-5. PubMed ID: 1703867
[TBL] [Abstract][Full Text] [Related]
16. Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.
Sárváry A; Szucs S; Balogh I; Becsky A; Bárdos H; Kávai M; Seligsohn U; Egbring R; Lopaciuk S; Muszbek L; Adány R
Cell Immunol; 2004 Apr; 228(2):81-90. PubMed ID: 15219459
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Crow AR; Song S; Siragam V; Lazarus AH
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Crow AR; Lazarus AH
Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
[TBL] [Abstract][Full Text] [Related]
20. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
Deng R; Balthasar JP
Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
